Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007341
Chunk: 74

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 74
---
 are delisted from a “national securities exchange” (that has registered with
the Commission under Section 6 of the Securities Exchange Act of 1934, as amended), (iii) if we effect (or will effect) a redemption of
all or substantially all of the deposited securities, or a cash or share distribution representing a return of all or substantially all
of the value of the deposited securities, (iv) there are no deposited securities with respect to Depositary Shares remaining, including
if the deposited securities are cancelled, or the deposit securities have been deemed to have no value, or (v) there occurs a merger,
consolidation, sale of assets or other transaction as a result of which securities or other property are delivered in exchange for or
in lieu of deposited securities, and (b) immediately without prior notice to the Company, any ADR holder or beneficial owner or any other
person if (i) required by any law, rule or regulation relating to sanctions by any governmental authority or body, (ii) the depositary
would be subject to liability under or pursuant to any law, rule or regulation, or (iii) required by any governmental authority or body,
in each case under (b) as determined by the depositary in its reasonable discretion.

If our Ordinary Shares are not listed and
publicly traded on a stock exchange or in a securities market as of the date so fixed for termination or if, for any reason, the depositary
does not sell the deposited securities, then after such date fixed for termination, the depositary shall use its reasonable efforts to
ensure that the Depositary Shares cease to be eligible for settlement within DTC and that neither DTC nor any of its nominees shall thereafter
be an ADR holder. At such time as the Depositary Shares cease to be DTC eligible and/or neither DTC nor any of its nominees is an ADR
holder, to the extent we are not, to the depositary’s knowledge, insolvent or in bankruptcy or liquidation, the depositary shall
(A) cancel all outstanding ADRs; (B) request DTC to provide the depositary with information on those holding Depositary Shares through
DTC and, upon receipt thereof, revise the ADR register to reflect the information provided by DTC; (C) instruct its custodian to deliver
all deposited securities to us, a subsidiary or affiliate of ours (the company representative) or an independent trust company engaged
by us (the trustee) to hold those